drugset / Trial / NCT05868733
A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa
Phase 2
Recruiting
612 enrolled
International AIDS Vaccine Initiative
Coalition for Epidemic Preparedness Innovations · collab
RandomizedSequentialTriple-blindPrevention
Summary
A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults and Children Residing in West Africa
Timeline
- Start
- 2024-03-06
- Primary completion
- 2026-12
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rVSV∆G-LASV-GPC | Vaccine | 2e+06 unknown | — |
| Subject | rVSV∆G-LASV-GPC | Vaccine | 1e+07 unknown | — |